First AD

Second AD

OncLive Peer Exchange® 

® Peer Exchange video program comprises lively expert panel discussions feature peer-to-peer exchanges providing authoritative insights, opinions, and perspectives on important issues facing today’s health care professionals. Episodes focus on updates and insights across solid and hematologic malignancies, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecological cancers, and hematologic malignancies. 

Myeloproliferative Neoplasms

INC-22-OSD1258 - /clinical/myeloproliferative-neoplasms

The OncLive Myeloproliferative Neoplasms condition center is a comprehensive resource for clinical news and expert insights on myeloproliferative neoplasms, including myelofibrosis, polycythemia vera, and essential thrombocythemia. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in myeloproliferative neoplasms.

Expert Insights Into the Management of MPNs

Peer Exchange

Abdulraheem Yacoub, MD, details the side effect profiles of the approved JAK inhibitors for myelofibrosis treatment.

Considering Toxicities and Side Effects of JAK Inhibitors in Patients with MF

An Overview of Myeloproliferative Neoplasms (MPNs)

Risk Assessment for Patients with Polycythemia Vera (PV)

Current Treatment Landscape for Patients With PV

Selecting a Frontline Therapy for Patients With PV

Ruxolitinib for the Management of PV

Ropeginterferon alfa-2b for the Treatment of PV

Reviewing the Types of Myelofibrosis 

The Role of Transplant in the Treatment of Patients With MF

COMFORT-I and COMFORT-II Data Review

Pacritinib and Fedratinib for the Treatment of MF

Sequencing Therapies in Patients with MF

Symptom Monitoring in Patients with MF

Exploring the Future of MF Treatment